Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:14 PM
Study NCT ID:
NCT03503058
Status:
COMPLETED
Last Update Posted:
2024-12-11
First Post:
2018-04-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria
Sponsor:
Sanaria Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-29
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-11
First Submit QC Date:
None
Study First Post Date:
2018-04-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-06
Last Update Post Date:
2024-12-11
Last Update Post Date Type:
ACTUAL